Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease

Journal article

Peer reviewed

Meagan Kubista, Grethel Perez Meek, Kyle Sramek, Mark Mullen and Rajesh R. Tampi

The Psychiatric times, Vol.41(2), p.29

02/01/2024

Abstract

Alzheimer's disease

Care and treatment

Clinical trials

Drug therapy

Monoclonal antibodies

1 Record Views

Title: Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease
Creators: Meagan Kubista
Grethel Perez Meek
Kyle Sramek
Mark Mullen
Rajesh R. Tampi
Publication Details: The Psychiatric times, Vol.41(2), p.29
Publisher: Intellisphere, LLC
Number of pages: 2
Identifiers: 991006241102802656
Academic Unit: Psychiatry
Language: English
Resource Type: Journal article